Hi Russ, I was a Bio MD shareholder. I am talking about the share dilution of 6 to 1 in favour of Allied Health.
I do know what I am talking about. The dilution did result in around 800 million shares on issue. If you wish to continue to ignore this then fine. But that is absolutely why we have this massive dilution now. I don't think that deal was very smart.
If Coridon was worth So much less than ADAPT CC. Then please explain the 6 for 1 share differential in favour of Allied?
- Forums
- ASX - By Stock
- AVR
- Global future
Global future, page-32
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.00 |
Change
0.200(2.27%) |
Mkt cap ! $190.2M |
Open | High | Low | Value | Volume |
$8.90 | $9.48 | $8.88 | $176.7K | 19.75K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 590 | $8.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.40 | 70 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 590 | 8.800 |
2 | 2067 | 8.680 |
1 | 260 | 8.510 |
1 | 300 | 8.500 |
1 | 2 | 8.420 |
Price($) | Vol. | No. |
---|---|---|
9.400 | 70 | 1 |
9.430 | 105 | 1 |
9.490 | 218 | 1 |
9.500 | 250 | 1 |
9.850 | 1000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online